Based on our analysis suggesting that cGAS and STING may influence chemotherapy and immunotherapy efficacy, we established a retrospective cohort of HNSCC patients treated with NACI to further investigate our findings. This evidence concerns the gene STING1 and head and neck squamous cell carcinoma.